Product Information
LDC7559 is a reactive oxygen species-dependent compound that has been found to be cytotoxic against cancer cells. It induces cell lysis by oxidative damage, causing the release of cytoplasmic contents into the extracellular space. This compound also inhibits the production of inflammatory compounds such as prostaglandins, leukotrienes, and cytokines. LDC7559 is currently in phase II clinical trials for treating inflammatory bowel disease and experimental colitis. LDC7559 has also shown anti-inflammatory properties in vitro and in vivo models of autoimmune diseases such as asthma, arthritis, psoriasis, and Crohn's disease.
Chemical properties
Technical inquiry about: 3D-HWD78201 LDC7559
If you want to request a quotation or place an order, please instead add the desired products to your cart and then request a quotation or order from the cart. It is faster, cheaper, and you will be able to benefit from the available discounts and other advantages.
